Ares Commercial Real Estate

ACRE

Market cap $261M

Ares Commercial faces headwinds from loan losses and office market overexposure, resulting in two dividend cuts in three years. ACRE trades at a steep 50% discount to book value, reflecting investor skepticism about its distributable earnings and portfolio quality. The REIT has shrunk its office loan portfolio by 46% since Q1'23 but still underearns its dividend, with an 80% coverage ratio in Q1'26.

Investors need to pay close attention to ACRE stock based on the movements in the options market lately.

Some REIT categories may be far riskier than they appear. Office exposure can hide inside diversified portfolios. High yields often come with costly tradeoffs.

ACRE, CWST and CCAP have been added to the Zacks Rank #5 (Strong Sell) List on June 16, 2026.

APLD, ACRE and SKY have been added to the Zacks Rank #5 (Strong Sell) List on June 9, 2026.

10%-plus yielding stocks are very popular. But most such stocks tend to destroy long-term wealth. A balanced 6–8% yield strategy usually wins.

Some popular REITs still offer big yields, but the coverage is weak. Mortgage REITs remain exposed to pandemic-era loans gone wrong.

Temporary vacancies and foreclosures crash REIT stock prices, creating a window to buy valuable real estate at a steep discount. Medical Properties Trust has moved past the Steward bankruptcy, with replacement tenants restoring the cash flow pipeline. After defensively shrinking its portfolio, Ares Commercial Real Estate is aggressively leveraging back up (from 1.1x to 1.9x) to drive earnings.

Ares Commercial Real Estate NYSE: ACRE reported a first-quarter loss as higher credit reserves tied to two large troubled loans weighed on results, while management said it continued to reshape the portfolio through new originations, asset resolutions and reduced office exposure.

Ares Commercial Real Estate Corporation (ACRE) Q1 2026 Earnings Call Transcript